These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2803457)
1. Pathogenesis and chemotherapy of experimental Legionella pneumophila infection in the chick embryo. Tzianabos AO; Rodgers FG Zentralbl Bakteriol; 1989 Sep; 271(3):293-303. PubMed ID: 2803457 [TBL] [Abstract][Full Text] [Related]
2. Electron microscopy of the pathology and chemotherapy of Legionella pneumophila infection in the chick embryo. Tzianabos AO; Rodgers FG Zentralbl Bakteriol; 1989 Oct; 271(4):466-74. PubMed ID: 2818797 [TBL] [Abstract][Full Text] [Related]
3. Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin. Horwitz MA; Silverstein SC J Clin Invest; 1983 Jan; 71(1):15-26. PubMed ID: 6848556 [TBL] [Abstract][Full Text] [Related]
4. The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs. Saito A; Koga H; Shigeno H; Watanabe K; Mori K; Kohno S; Shigeno Y; Suzuyama Y; Yamaguchi K; Hirota M J Antimicrob Chemother; 1986 Aug; 18(2):251-60. PubMed ID: 3759736 [TBL] [Abstract][Full Text] [Related]
5. In vivo susceptibility of the Legionnaires disease bacterium to ten antimicrobial agents. Lewis VJ; Thacker WL; Shepard CC; McDade JE Antimicrob Agents Chemother; 1978 Mar; 13(3):419-22. PubMed ID: 263885 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Legionnaires' disease. Current recommendations. Roig J; Carreres A; Domingo C Drugs; 1993 Jul; 46(1):63-79. PubMed ID: 7691508 [TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental Legionnaires' disease by aerosol administration of rifampicin, ciprofloxacin, and erythromycin. Fitzgeorge RB; Baskerville A; Featherstone AS Lancet; 1986 Mar; 1(8479):502-3. PubMed ID: 2869238 [No Abstract] [Full Text] [Related]
11. The activity of imipenem on Legionella pneumophila, with a note on the treatment of two cases. Farrell ID; Barker J; Chiodini PL; Hutchison JG; Geddes AM J Antimicrob Chemother; 1985 Jul; 16(1):61-5. PubMed ID: 3862660 [TBL] [Abstract][Full Text] [Related]
12. The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes. Fitzgeorge RB; Featherstone AS; Baskerville A J Antimicrob Chemother; 1988 Sep; 22 Suppl C():53-7. PubMed ID: 3182462 [TBL] [Abstract][Full Text] [Related]
13. Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease. Edelstein PH Antimicrob Agents Chemother; 1991 Jan; 35(1):5-9. PubMed ID: 2014980 [TBL] [Abstract][Full Text] [Related]
14. Application of DNA probes to antimicrobial susceptibility testing of Legionella pneumophila. Reznicek M; Bale M; Pfaller M Diagn Microbiol Infect Dis; 1991; 14(1):7-10. PubMed ID: 2013212 [TBL] [Abstract][Full Text] [Related]
15. Studies on ciprofloxacin therapy of experimental Legionnaires' disease. Fitzgeorge RB; Gibson DH; Jepras R; Baskerville A J Infect; 1985 May; 10(3):194-203. PubMed ID: 3161954 [TBL] [Abstract][Full Text] [Related]